F2G and Shionogi’s olorofim met its goals in a late-stage study, setting the stage for an FDA filing this year ...

The program, being piloted in China, aims to celebrate professional achievements, scientific contributions, and social impact ...

A ruthenium-based reaction exploits the stronger carbon-deuterium bond to enrich one mirror-image form from a racemic mixture ...

Ira Remsen, founding faculty member at Johns Hopkins University, established the US’s first graduate program in chemistry ...

Researchers at the Swiss Federal Institute of Technology (ETH), Zurich, have designed an implant that converts excess blood ...

The surface of an Andes virus is covered in protein spikes with which it attaches to human cells. Researchers have now mapped ...

Your genome could be hiding secrets about your health. Knowing them might be more trouble than it's worth ...

Estuary Biotherapeutics, which is developing gene therapies to treat kidney disease, has launched with $103 million in ...

Automated laboratory discovers promising palladium materials, but commercial use remains distant ...

The EDF’s concern is that equipment-level standards do not provide protections that facility permitting standards—to which ...

Mixing an electrochemically active cathode material powder (left) with a new fluorine-free binder (middle) and a nontoxic ...

In a recent related study, researchers in China also developed a heterogeneous hydroformylation catalyst based on rhodium.